Why the study?
Does rivaroxaban improve outcomes in a patient with spontaneous ovarian vein thrombosis caused by Factor V Leiden homozygosity?
Population
30-year-old previously healthy woman with acute, spontaneous, left-ovarian vein thrombosis with proximal…
Design
Case_report
Follow-up
3 months
Authors
Loading...
May support rivaroxaban for ovarian vein thrombosis with Factor V Leiden; hypothesis-generating and should not yet change practice.
Does rivaroxaban improve outcomes in a patient with spontaneous ovarian vein thrombosis caused by Factor V Leiden homozygosity?
This case suggests that rivaroxaban may be a safe and effective alternative to vitamin K antagonists for the long-term treatment of extra-axial thromboses such as ovarian vein thrombosis.
Cook et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: